Zomedica Corp. (NYSE American: ZOM) today announced that Larry Heaton, CEO, will be attending the Q3 Virtual Investor Summit. During the presentation, Zomedica Chief Executive Officer, Larry Heaton, will highlight the Company's recent acquisitions and integration of PulseVet and the assets of Revo Squared and Assisi Animal Health, and the resulting transformational business strategy, noteworthy collaborations and partnerships, and the broader going-forward corporate vision. The presentation will be webcast and an archived recording will be made available in the Investors' section of the Zomedica website.
Event: | Q3 Investor Summit |
Date: | August 16 & 17th, 2022 |
Presentation: | August 16 @ 12:30 p.m. ET |
Location: | https://us06web.zoom.us/webinar/register/WN_FfufrTaxTkSpRc1P4NPAAA |
Company Description
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica's mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. Zomedica's TRUFORMA® is an in-clinic biosensor platform offering reference lab quality results for diagnoses of thyroid and adrenal disorders. The PulseVet® line is the leader in veterinary shock wave therapy, and has recently launched technology capable of delivering true electrohydraulic shock wave energy without the need for sedation.
Investor Relations Contact:
PCG Advisory Group
Kirin Smith, President
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1.646.823.8656
About Investor Summit Group
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.12 |
Daily Volume: | 12,083,028 |
Market Cap: | US$117.590M |
November 27, 2024 November 14, 2024 November 08, 2024 November 07, 2024 October 24, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB